Fig. 2From: Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levelsComparison of complete and partial remission rate between rituximab and cyclophosphamide groups in IMN patientsCR, complete remission; PR, partial remissionBack to article page